nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A central nervous system CD56 positive multiple myeloma patient with a t(11;14) (q11;q32): A case report
|
Gozzetti, Alessandro |
|
2011 |
35 |
11 |
p. e206-e208 nvt p. |
artikel |
2 |
Acquired alpha thalassemia myelodyslastic/myeloproliferative syndrome (ATMDS): Evolution on hypomethylating agent therapy
|
Rose, Christian |
|
2011 |
35 |
11 |
p. e203-e205 nvt p. |
artikel |
3 |
A novel gene LRP5 on 11q13.2 is rearranged in two patients with acute myeloid leukemia
|
Šárová, Iveta |
|
2011 |
35 |
11 |
p. e200-e202 nvt p. |
artikel |
4 |
Anti-myelin associated glycoprotein neuropathy responding to lenalidomide
|
Larsen, Louise Haahr |
|
2011 |
35 |
11 |
p. e198-e199 nvt p. |
artikel |
5 |
Association of KIR2DS4 gene with susceptibility to leukemia: Chinese–Polish discrepancy
|
Kuśnierczyk, Piotr |
|
2011 |
35 |
11 |
p. 1540- 1 p. |
artikel |
6 |
Biallelic ETV6 rearrangements by recurrent translocations t(7;12)(p15;p13) and t(3;12)(q26.2;p13) in acute myeloid leukemia
|
Yamamoto, Katsuya |
|
2011 |
35 |
11 |
p. e212-e214 nvt p. |
artikel |
7 |
Cooperation between somatic Ikaros and Notch1 mutations at the inception of T-ALL
|
Sontani, Yovina |
|
2011 |
35 |
11 |
p. 1512-1519 8 p. |
artikel |
8 |
Decreased TET2 gene expression during chronic myeloid leukemia progression
|
Albano, F. |
|
2011 |
35 |
11 |
p. e220-e222 nvt p. |
artikel |
9 |
Diagnostic testing, treatment, cost of care, and survival among registered and non-registered patients with myelodysplastic syndromes
|
Craig, Benjamin M. |
|
2011 |
35 |
11 |
p. 1453-1456 4 p. |
artikel |
10 |
Disease progression mechanism in myelodysplastic syndromes: Insight into the role of the microenvironment
|
Ishibashi, Mariko |
|
2011 |
35 |
11 |
p. 1449-1452 4 p. |
artikel |
11 |
Editorial Board
|
|
|
2011 |
35 |
11 |
p. CO2- 1 p. |
artikel |
12 |
Efficacy of novel histone deacetylase inhibitor, AR42, in a mouse model of, human T-lymphotropic virus type 1 adult T cell lymphoma
|
Zimmerman, Bevin |
|
2011 |
35 |
11 |
p. 1491-1497 7 p. |
artikel |
13 |
Expression of liquoral neuroprotection markers in children with acute lymphoblastic leukemia
|
Chiaretti, Antonio |
|
2011 |
35 |
11 |
p. 1467-1471 5 p. |
artikel |
14 |
Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS
|
Park, S. |
|
2011 |
35 |
11 |
p. 1530-1533 4 p. |
artikel |
15 |
Increased RANKL and IL-6 levels might result in high bone turnover in a case of a CD34+/CD117+/myeloperoxidase+dim acute myeloid leukemia presenting with severe hypercalcemia and lumbar spine fractures
|
Giannakoulas, Nikolaos C. |
|
2011 |
35 |
11 |
p. e188-e189 nvt p. |
artikel |
16 |
Inhibiting HDACs in a preclinical model of HTLV-1-induced adult T-cell lymphoma
|
Harrod, Robert |
|
2011 |
35 |
11 |
p. 1436-1437 2 p. |
artikel |
17 |
Inhibition of K562 leukemia angiogenesis and growth by selective Na+/H+ exchanger inhibitor cariporide through down-regulation of pro-angiogenesis factor VEGF
|
Gao, Wei |
|
2011 |
35 |
11 |
p. 1506-1511 6 p. |
artikel |
18 |
In vitro synergism between LFA-1 targeting leukotoxin (Leukothera™) and standard chemotherapeutic agents in leukemia cells
|
Gupta, Anukriti |
|
2011 |
35 |
11 |
p. 1498-1505 8 p. |
artikel |
19 |
Involvement of osteopontin and its signaling molecule CD44 in clinicopathological features of adult T cell leukemia
|
Chagan-Yasutan, Haorile |
|
2011 |
35 |
11 |
p. 1484-1490 7 p. |
artikel |
20 |
Isolated 5p isochromosome in myelodysplastic syndrome: Report of the first case
|
Douet-Guilbert, Nathalie |
|
2011 |
35 |
11 |
p. e193-e197 nvt p. |
artikel |
21 |
Lenalidomide in del 5q MDS: Responses and side effects revisited
|
Tiu, Ramon V. |
|
2011 |
35 |
11 |
p. 1440-1441 2 p. |
artikel |
22 |
LNK can also be mutated outside PH and SH2 domains in myeloproliferative neoplasms with and without V617FJAK2 mutation
|
Hurtado, C. |
|
2011 |
35 |
11 |
p. 1537-1539 3 p. |
artikel |
23 |
Low-level Bcr–Abl mutations are very rare in chronic myeloid leukemia patients who are in major molecular response on first-line nilotinib
|
Soverini, Simona |
|
2011 |
35 |
11 |
p. 1527-1529 3 p. |
artikel |
24 |
Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma
|
Drain, Stephen |
|
2011 |
35 |
11 |
p. 1457-1463 7 p. |
artikel |
25 |
Multiplex ligation-dependent probe amplification for detection of chromosomal abnormalities in myelodysplastic syndrome and acute myeloid leukemia
|
Donahue, Amber C. |
|
2011 |
35 |
11 |
p. 1477-1483 7 p. |
artikel |
26 |
Myelodysplastic syndromes and bone marrow microenvironment
|
Della Porta, Matteo Giovanni |
|
2011 |
35 |
11 |
p. 1442-1443 2 p. |
artikel |
27 |
Nilotinib therapy does not induce consistent modifications of cholesterol metabolism resulting in clinical consequences
|
Breccia, Massimo |
|
2011 |
35 |
11 |
p. e215-e216 nvt p. |
artikel |
28 |
Pneumocystis jirovecii pneumonia as a complication of bendamustine in a patient receiving bendamustine plus rituximab for marginal zone lymphoma
|
Carter, Stephanie J. |
|
2011 |
35 |
11 |
p. e223-e224 nvt p. |
artikel |
29 |
Polymorphism of the thymidylate synthase gene and risk of relapse in childhood ALL
|
Pietrzyk, Jacek J. |
|
2011 |
35 |
11 |
p. 1464-1466 3 p. |
artikel |
30 |
Primary cutaneous CD30 positive anaplastic large cell lymphoma – Report of a case treated with bexarotene
|
Oliveira, Ana |
|
2011 |
35 |
11 |
p. e190-e192 nvt p. |
artikel |
31 |
Primary uterine localization of malt lymphoma: A case report and literature review
|
De Angelis, Federico |
|
2011 |
35 |
11 |
p. e185-e187 nvt p. |
artikel |
32 |
Promotional etiology for common childhood acute lymphoblastic leukemia: The infective lymphoid recovery hypothesis
|
Richardson, Richard B. |
|
2011 |
35 |
11 |
p. 1425-1431 7 p. |
artikel |
33 |
Response to bortezomib of a patient with scleromyxedema refractory to other therapies
|
Migkou, Magdalini |
|
2011 |
35 |
11 |
p. e209-e211 nvt p. |
artikel |
34 |
Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population
|
Pastorczak, Agata |
|
2011 |
35 |
11 |
p. 1534-1536 3 p. |
artikel |
35 |
Searching for surrogates for IGHV mutations in chronic lymphocytic leukemia
|
Hamblin, Terry J. |
|
2011 |
35 |
11 |
p. 1432-1435 4 p. |
artikel |
36 |
Synergistic targeting of leukemia with leukotoxin and chemotherapy
|
Kreitman, Robert J. |
|
2011 |
35 |
11 |
p. 1438-1439 2 p. |
artikel |
37 |
Three copies of isochromosome 8q in Ph+ B-cell acute lymphoblastic leukemia
|
Soriani, Silvia |
|
2011 |
35 |
11 |
p. e217-e219 nvt p. |
artikel |
38 |
Treatment by Lenalidomide in lower risk myelodysplastic syndrome with 5q deletion—The GFM experience
|
Le Bras, Fabien |
|
2011 |
35 |
11 |
p. 1444-1448 5 p. |
artikel |
39 |
Weekly standard doses of rh-EPO are highly effective for the treatment of anemic patients with low-intermediate 1 risk myelodysplastic syndromes
|
Balleari, Enrico |
|
2011 |
35 |
11 |
p. 1472-1476 5 p. |
artikel |
40 |
Wilms’ tumor 1-specific cytotoxic T lymphocytes can be expanded from adult donors and cord blood
|
Krishnadas, Deepa K. |
|
2011 |
35 |
11 |
p. 1520-1526 7 p. |
artikel |